Thus to reset immune abnormalities in GCA, glucocorticoid treatment may have greater efficacy with the addition of other therapies [6], such as Serp-1, that in other models is reported to target macrophage, Th1 and Th17 cell responses [12]. This evidence concerns the gene SERP1 and temporal arteritis.